FDA Speaks Out on the Future of Cannabis-containing Food Products
On Friday, the U.S. Food and Drug Administration (FDA) released a statement regarding its current, science-based stance on the use of cannabis or cannabis-derived compounds, including cannabidiol (CBD), in various products including food.
The statement, authored by FDA’s Principal Deputy Commissioner Amy Abernethy, M.D., Ph.D., and Principal Associate Commissioner for Policy Lowell Schiller, J.D., shares how the agency is approaching decision-making as public interest cannabis products rises. The statement was deemed necessary by the agency as some state laws have changed in recent years and an increasing number of products that contain cannabis are introduced to the market.